These molecules are exposed to series of reactions such as condensation, ring formation, and hydrolysis
Gruber A, Horwood F, Sithole J, Ali NJ, Idris I
Endocrinological disorders
It has already improved the lives of chronically overweight people
"The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying." Diabetes, Obesity and Metabolism
They conclude: Given the severe societal, familial, and economic burden of diabetes-related dementia, these findings raise important considerations about the role of GLP-1 [receptor agonists] as first-line therapies in [type 2 diabetes] management